Strahl L, Borgmann H, Struck J, Salem J, Kuru T
Cancer Rep (Hoboken). 2025; 8(3):e70120.
PMID: 40071469
PMC: 11897801.
DOI: 10.1002/cnr2.70120.
Durant A, Nguyen M, Choudry M, Mi L, Andrews J, Tyson M
Bladder Cancer. 2025; 10(4):270-277.
PMID: 40035080
PMC: 11864239.
DOI: 10.1177/23523735241303350.
Ahmadi N, Shafee H, Moudi E
Asian J Urol. 2024; 11(4):625-632.
PMID: 39533991
PMC: 11551389.
DOI: 10.1016/j.ajur.2023.04.007.
Guigui A, Basile G, Zattoni F, Gallioli A, Verri P, Aumatell J
World J Urol. 2024; 42(1):480.
PMID: 39133324
DOI: 10.1007/s00345-024-05192-x.
Levy S, Pericart S, Bajeot A, Fakhfakh S, Lesourd M, Soulie M
World J Urol. 2024; 42(1):475.
PMID: 39115589
PMC: 11310258.
DOI: 10.1007/s00345-024-05175-y.
Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study.
Chan K, Hampson A, Hayes J, Rabinowitz J, Vasdev N
BJUI Compass. 2023; 4(5):568-574.
PMID: 37636209
PMC: 10447208.
DOI: 10.1002/bco2.250.
When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center.
Bhirud D, Mittal A, Kumar S, Narain T, Kishore S, Navriya S
Indian J Surg Oncol. 2022; 13(3):604-611.
PMID: 36187522
PMC: 9515286.
DOI: 10.1007/s13193-022-01516-8.
Genitourinary tumors.
Herr H, Sogani P, Eastham J
J Surg Oncol. 2022; 126(5):926-932.
PMID: 36087085
PMC: 10671100.
DOI: 10.1002/jso.27031.
An Evaluation of Peer-Rated Surgical Skill and its Relationship With Detrusor Muscle Sampling in Transurethral Resection of Bladder Tumor.
Pham M, Ko O, Huang R, Vo A, Tsai K, Lai J
Urology. 2022; 169:134-140.
PMID: 36049631
PMC: 10099284.
DOI: 10.1016/j.urology.2022.07.057.
The application value of multi-parameter cystoscope in improving the accuracy of preoperative bladder cancer grading.
Wu Q, Cai L, Yuan B, Cao Q, Zhuang J, Bao M
BMC Urol. 2022; 22(1):111.
PMID: 35850869
PMC: 9295426.
DOI: 10.1186/s12894-022-01054-z.
Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
Ye L, Chen Y, Xu H, Xie H, Yao J, Liu J
Eur Radiol. 2022; 32(9):6480-6492.
PMID: 35362750
DOI: 10.1007/s00330-022-08696-5.
Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule.
Malik K, Raja A, Ravishankar L, Narayanaswamy K, Radhakrishnan V, Sagar T
Indian J Surg Oncol. 2022; 12(4):796-801.
PMID: 35110905
PMC: 8764004.
DOI: 10.1007/s13193-021-01439-w.
Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K, Jeong S, Yoo S, Ku J
Investig Clin Urol. 2022; 63(1):14-20.
PMID: 34983118
PMC: 8756150.
DOI: 10.4111/icu.20210314.
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.
Bhindi B, Kool R, Kulkarni G, Siemens D, Aprikian A, Breau R
Can Urol Assoc J. 2021; 15(8):E424-E460.
PMID: 33938798
PMC: 8418246.
DOI: 10.5489/cuaj.7367.
Utility of first order MRI-Texture analysis parameters in the prediction of histologic grade and muscle invasion in urinary bladder cancer: a preliminary study.
Razik A, Das C, Sharma R, Malla S, Sharma S, Seth A
Br J Radiol. 2021; 94(1122):20201114.
PMID: 33882245
PMC: 8173695.
DOI: 10.1259/bjr.20201114.
Role of surgeon experience in the outcome of transurethral resection of bladder tumors.
Ali M, Eltobgy A, Ismail I, Ghobish A
Urol Ann. 2021; 12(4):341-346.
PMID: 33776330
PMC: 7992518.
DOI: 10.4103/UA.UA_138_19.
Utility and Safety of Repeat Transurethral Resection of Bladder Tumor Performed at a Tertiary Center.
Raja A, Malik K, Arunandhichelvan A, Kathiresan N, Ravishankar L
South Asian J Cancer. 2020; 9(2):86-89.
PMID: 33354550
PMC: 7745745.
DOI: 10.1055/s-0040-1721213.
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit.
Krajewski W, Moschini M, Nowak L, Poletajew S, Tukiendorf A, Afferi L
J Clin Med. 2020; 9(10).
PMID: 33076249
PMC: 7602446.
DOI: 10.3390/jcm9103306.
Non-muscle-invasive Bladder Cancer: Overview and Contemporary Treatment Landscape of Neoadjuvant Chemoablative Therapies.
Matulewicz R, Steinberg G
Rev Urol. 2020; 22(2):43-51.
PMID: 32760227
PMC: 7393683.
Genitourinary cancer management during a severe pandemic: Utility of rapid communication tools and evidence-based guidelines.
Shah P, Kim F, Mian B
BJUI Compass. 2020; 1(2):45-59.
PMID: 32537615
PMC: 7280667.
DOI: 10.1002/bco2.18.